Business

ACW HY26 results - XanaMIA pivotal Alzheimers trial progress

ACW HY26 results - XanaMIA pivotal Alzheimers trial progress

Actinogen Medical LimitedFebruary 25, 20265
ACW HY26 results - XanaMIA pivotal Alzheimers trial progress

About this update from Actinogen Medical Limited

Actinogen Medical Ltd has released a press release. View Attachment

View stock analysis, news, and events for Actinogen Medical Limited

More from Actinogen Medical Limited

All Actinogen Medical Limited news →